Financials
- Market Capitalization 730.2 M
- Employee 121
- Founded 2013
- CEO N/A
- Website www.solidbio.com
- Headquarter Delaware, United States
- FIGI BBG00JN4FXG8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.83
Rapporto prezzo/fatturato
530.1
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2582 | ACHV Achieve Life Sciences, Inc. - Common Shares | 7.13 USD | -3.78% | +2.15% | +0.99% | +128.53% | 733.69 M USD | ||
| 2596 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 13.19 USD | -1.05% | +1.77% | -3.30% | +16.73% | 728.67 M USD | ||
| 2603 | DSGN Design Therapeutics, Inc. - Common Stock | 11.52 USD | -1.12% | -5.34% | -21.69% | +70.67% | 720.94 M USD | ||
| 2604 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.63 USD | -2.98% | -7.39% | -17.68% | +7.95% | 725.28 M USD |